
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Establishment Labs Holdings Inc (ESTA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: ESTA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $55.44
1 Year Target Price $55.44
5 | Strong Buy |
2 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -38.65% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.19B USD | Price to earnings Ratio - | 1Y Target Price 55.44 |
Price to earnings Ratio - | 1Y Target Price 55.44 | ||
Volume (30-day avg) 8 | Beta 0.83 | 52 Weeks Range 26.55 - 50.85 | Updated Date 08/28/2025 |
52 Weeks Range 26.55 - 50.85 | Updated Date 08/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.08 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-07 | When - | Estimate -0.53 | Actual -0.57 |
Profitability
Profit Margin -49.89% | Operating Margin (TTM) -27.5% |
Management Effectiveness
Return on Assets (TTM) -12.78% | Return on Equity (TTM) -261.18% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1405994035 | Price to Sales(TTM) 6.69 |
Enterprise Value 1405994035 | Price to Sales(TTM) 6.69 | ||
Enterprise Value to Revenue 7.92 | Enterprise Value to EBITDA -26.29 | Shares Outstanding 28970700 | Shares Floating 16952516 |
Shares Outstanding 28970700 | Shares Floating 16952516 | ||
Percent Insiders 10.74 | Percent Institutions 104.33 |
Upturn AI SWOT
Establishment Labs Holdings Inc

Company Overview
History and Background
Establishment Labs Holdings Inc. was founded in 2004. It is a global medical technology company focused on breast aesthetics and reconstruction technologies. The company has focused on innovation and expanding its global reach.
Core Business Areas
- Breast Aesthetics: Develops, manufactures, and markets a portfolio of silicone gel-filled breast implants, primarily Motiva Implants, for aesthetic enhancement.
- Breast Reconstruction: Offers products for breast reconstruction procedures following mastectomy due to breast cancer.
- Early Detection: Develops and offers products for breast health, including early detection technologies.
Leadership and Structure
Juan Josu00e9 Chacu00f3n-Quiru00f3s is the CEO. The company has a board of directors and a management team overseeing different functions like R&D, sales, marketing, and operations. The structure is a typical multinational corporation with regional headquarters.
Top Products and Market Share
Key Offerings
- Motiva Implants: Motiva Implants are its flagship product, a line of silicone gel-filled breast implants known for their advanced surface technology and safety features. Market share data fluctuates but estimates range from 10-15% globally. The competitors are Allergan (ABBV), Mentor (JNJ), Sientra (SIEN).
- Divina Breast Reconstruction System: The Divina breast reconstruction system aids in breast reconstruction procedures by providing surgeons with a comprehensive solution. Market share is growing but still relatively small. Competitors include Allergan (ABBV), Mentor (JNJ).
Market Dynamics
Industry Overview
The global breast implant market is driven by increasing demand for aesthetic procedures and breast reconstruction. The market is moderately consolidated, with a few major players dominating. Growth is fueled by technological advancements and rising disposable incomes.
Positioning
Establishment Labs positions itself as a premium provider of innovative and safe breast implant technologies, focusing on patient safety and aesthetic outcomes. Their competitive advantage lies in their advanced Motiva implant technology and focus on minimizing complications.
Total Addressable Market (TAM)
The total market is estimated around $2 billion. Establishment Labs is well positioned in this market focusing on growth and innovation.
Upturn SWOT Analysis
Strengths
- Innovative product portfolio (Motiva Implants)
- Strong brand reputation
- Focus on safety and aesthetics
- Global presence with strong growth in key markets
- Proprietary technology
Weaknesses
- Relatively smaller market share compared to larger competitors
- Higher price point may limit market reach
- Reliance on regulatory approvals for new products
- Geographic concentration of manufacturing
- Requires substantial investment in R&D and marketing.
Opportunities
- Expanding into new geographic markets
- Developing new products and technologies
- Increasing awareness of breast reconstruction options
- Strategic partnerships and acquisitions
- Capitalizing on the growing demand for aesthetic procedures
Threats
- Competition from established players with larger market share
- Product liability claims and recalls
- Changing regulatory landscape
- Economic downturn affecting consumer spending
- Adverse publicity regarding breast implant safety
Competitors and Market Share
Key Competitors
- ABBV
- JNJ
- SIEN
Competitive Landscape
Establishment Labs differentiates itself through innovation and product safety. However, its smaller size and higher price point present challenges against larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Establishment Labs has experienced strong revenue growth in recent years.
Future Projections: Analysts project continued revenue growth driven by geographic expansion and new product launches.
Recent Initiatives: Recent initiatives include expanding production capacity, pursuing regulatory approvals in key markets, and investing in clinical trials.
Summary
Establishment Labs is an innovative company in the breast aesthetics market with a focus on safety and aesthetics. The company faces strong competition from larger players and needs to successfully expand into new markets. Continuous regulatory approvals are critical for its success and financial stability. Overall, the company is considered to be very strong with solid results year on year.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Analyst Reports
- Industry Publications
Disclaimers:
The data provided is based on available information and estimates. Market share figures are approximate and subject to change. Investment decisions should be based on thorough research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Establishment Labs Holdings Inc
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2018-07-19 | CEO & Director Mr. Fillipo Peter Caldini | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1056 | |
Full time employees 1056 |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.